News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
174,738 Results
Type
Article (12875)
Company Profile (23)
Press Release (161840)
Multimedia
Podcasts (9)
Webinars (5)
Section
Business (48423)
Career Advice (610)
Deals (9067)
Drug Delivery (30)
Drug Development (27914)
Employer Resources (69)
FDA (4665)
Job Trends (3843)
News (90681)
Policy (7799)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1072)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (31)
Alliances (13626)
ALS (37)
Alzheimer's disease (432)
Antibody-drug conjugate (ADC) (22)
Approvals (4676)
Artificial intelligence (58)
Autoimmune disease (8)
Automation (3)
Bankruptcy (70)
Best Places to Work (3194)
BIOSECURE Act (6)
Biosimilars (34)
Biotechnology (11)
Bladder cancer (20)
Brain cancer (8)
Breast cancer (79)
Cancer (551)
Cardiovascular disease (60)
Career advice (512)
Career pathing (13)
CAR-T (45)
Cell therapy (107)
Cervical cancer (9)
Clinical research (23727)
Collaboration (166)
Compensation (14)
Complete response letters (1)
COVID-19 (1077)
CRISPR (8)
C-suite (52)
Cystic fibrosis (20)
Data (699)
Denatured (6)
Depression (8)
Diabetes (92)
Diagnostics (1701)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (37)
Drug pricing (38)
Drug shortages (16)
Duchenne muscular dystrophy (31)
Earnings (14219)
Editorial (16)
Employer branding (5)
Employer resources (63)
Events (20739)
Executive appointments (181)
FDA (4985)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (194)
Gene editing (17)
Generative AI (6)
Gene therapy (81)
GLP-1 (265)
Government (1173)
Grass and pollen (1)
Guidances (10)
Healthcare (5372)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (30)
Indications (6)
Infectious disease (1121)
Inflammatory bowel disease (52)
Inflation Reduction Act (4)
Influenza (14)
Intellectual property (16)
Interviews (104)
IPO (3422)
IRA (19)
Job creations (772)
Job search strategy (450)
Kidney cancer (2)
Labor market (6)
Layoffs (77)
Leadership (7)
Legal (1521)
Liver cancer (21)
Lung cancer (61)
Lymphoma (41)
Machine learning (1)
Management (22)
Manufacturing (66)
MASH (32)
Medical device (3159)
Medtech (3161)
Mergers & acquisitions (5788)
Metabolic disorders (210)
Multiple sclerosis (38)
NASH (15)
Neurodegenerative disease (21)
Neuropsychiatric disorders (3)
Neuroscience (607)
NextGen: Class of 2025 (1994)
Non-profit (1631)
Northern California (502)
Obesity (96)
Opinion (46)
Ovarian cancer (15)
Pain (31)
Pancreatic cancer (20)
Parkinson's disease (54)
Partnered (7)
Patents (28)
Patient recruitment (33)
Peanut (17)
People (17228)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5259)
Phase II (10196)
Phase III (9676)
Pipeline (281)
Policy (53)
Postmarket research (1147)
Preclinical (1896)
Press Release (29)
Prostate cancer (34)
Psychedelics (9)
Radiopharmaceuticals (62)
Rare diseases (106)
Real estate (1372)
Recruiting (23)
Regulatory (5713)
Reports (13)
Research institute (891)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (18)
Schizophrenia (22)
Series A (46)
Series B (29)
Service/supplier (2)
Sickle cell disease (12)
Southern California (484)
Special edition (2)
Spinal muscular atrophy (62)
Sponsored (4)
Startups (1178)
Stomach cancer (4)
Supply chain (15)
Tariffs (6)
The Weekly (3)
United States (4709)
Vaccines (277)
Venture capitalists (8)
Weight loss (69)
Women's health (14)
Worklife (6)
Date
Last 7 days (103)
Last 30 days (511)
Last 365 days (7957)
2025 (2260)
2024 (8392)
2023 (9562)
2022 (12847)
2021 (14429)
2020 (14006)
2019 (13490)
2018 (10427)
2017 (9478)
2016 (9133)
2015 (10803)
2014 (7356)
2013 (5763)
2012 (6225)
2011 (6605)
2010 (5694)
Location
Africa (252)
Alabama (7)
Alaska (4)
Arizona (41)
Arkansas (2)
Asia (12466)
Australia (2396)
California (1179)
Canada (369)
China (143)
Colorado (50)
Connecticut (49)
Delaware (35)
Europe (33197)
Florida (165)
Georgia (70)
Idaho (14)
Illinois (141)
India (9)
Indiana (85)
Iowa (2)
Japan (65)
Kansas (29)
Kentucky (7)
Louisiana (5)
Maine (11)
Maryland (213)
Massachusetts (788)
Michigan (38)
Minnesota (83)
Missouri (17)
Montana (6)
Nebraska (6)
Nevada (17)
New Hampshire (10)
New Jersey (431)
New Mexico (7)
New York (461)
North Carolina (172)
Northern California (502)
Ohio (36)
Oklahoma (3)
Oregon (4)
Pennsylvania (286)
Puerto Rico (3)
Rhode Island (4)
South America (374)
South Carolina (7)
Southern California (484)
Tennessee (17)
Texas (145)
Utah (19)
Virginia (26)
Washington D.C. (6)
Washington State (156)
Wisconsin (10)
174,738 Results for "werfen group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Werfen Receives US FDA 510(k) Clearance for Aptiva® Antiphospholipid Syndrome Reagents
January 13, 2025
·
2 min read
Press Releases
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
October 9, 2024
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Deals
Werfen Completes Acquisition of Immucor, Inc., Expanding Leadership in Specialized Diagnostics
Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.
March 15, 2023
·
3 min read
Press Releases
Devonian Health Group Reports Second Quarter 2025 Financial Results
April 15, 2025
·
6 min read
Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays
Seegene Inc., a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnostics, to advance discussions on the expansion of its current collaboration for the Spanish and Portuguese marketplaces through Seegene’s OneSystem™ Business.
June 14, 2023
·
2 min read
Press Releases
Pharming Group to participate in April 2024 investor conferences
March 28, 2025
·
1 min read
Press Releases
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
April 2, 2025
·
2 min read
Press Releases
Global Hemp Group Announces Private Placement and Corporate Update
March 18, 2025
·
5 min read
Press Releases
Precision Medicine Group Names Pharma Services Innovator, Eric Hodgins, as Chief Information and Technology Officer
April 16, 2025
·
3 min read
1 of 17,474
Next
